435 related articles for article (PubMed ID: 22312833)
21. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report.
Burks AW; Calderon MA; Casale T; Cox L; Demoly P; Jutel M; Nelson H; Akdis CA
J Allergy Clin Immunol; 2013 May; 131(5):1288-96.e3. PubMed ID: 23498595
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma--a placebo controlled study.
Mungan D; Misirligil Z; Gürbüz L
Ann Allergy Asthma Immunol; 1999 May; 82(5):485-90. PubMed ID: 10353581
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma.
Ozdemir C; Yazi D; Gocmen I; Yesil O; Aydogan M; Semic-Jusufagic A; Bahceciler NN; Barlan IB
Pediatr Allergy Immunol; 2007 Sep; 18(6):508-15. PubMed ID: 17680909
[TBL] [Abstract][Full Text] [Related]
24. Allergy immunotherapy tablet: Grazax® for the treatment of grass pollen allergy.
Senna GE; Calderon M; Milani M
Expert Rev Clin Immunol; 2011 Jan; 7(1):21-7. PubMed ID: 21162646
[TBL] [Abstract][Full Text] [Related]
25. Advances in upper airway diseases and allergen immunotherapy in 2007.
Saltoun C; Avila PC
J Allergy Clin Immunol; 2008 Sep; 122(3):481-7. PubMed ID: 18694591
[TBL] [Abstract][Full Text] [Related]
26. Advances in upper airway diseases and allergen immunotherapy.
Nelson HS
J Allergy Clin Immunol; 2007 Apr; 119(4):872-80. PubMed ID: 17292953
[TBL] [Abstract][Full Text] [Related]
27. [Specific immunotherapy of allergic diseases: application, effect and side-effects (author's transl)].
Jarisch R; Sandor I; Götz M; Popow C
Wien Klin Wochenschr Suppl; 1980; 117():15-8. PubMed ID: 6936976
[TBL] [Abstract][Full Text] [Related]
28. [Specific desensitization with allergen extracts absorbed on calcium phosphate (Pasteur Institute). Clinical and biological study apropos of 107 cases].
Lecadet A; Ickovic MR; Thibaudon M
Allerg Immunol (Paris); 1988 Apr; 20(4):153, 155-6, 158-60. PubMed ID: 3401311
[TBL] [Abstract][Full Text] [Related]
29. House dust mite-specific immunotherapy alters the natural course of atopic march.
Tang RB
J Chin Med Assoc; 2020 Feb; 83(2):109-112. PubMed ID: 32015265
[TBL] [Abstract][Full Text] [Related]
30. [Specific and nonspecific (anti-IgE) immunotherapy of allergic diseases].
Pichler WJ
Ther Umsch; 2001 May; 58(5):329-36. PubMed ID: 11407237
[TBL] [Abstract][Full Text] [Related]
31. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
[TBL] [Abstract][Full Text] [Related]
32. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.
Senti G; Johansen P; Haug S; Bull C; Gottschaller C; Müller P; Pfister T; Maurer P; Bachmann MF; Graf N; Kündig TM
Clin Exp Allergy; 2009 Apr; 39(4):562-70. PubMed ID: 19226280
[TBL] [Abstract][Full Text] [Related]
33. Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction.
Staden U; Rolinck-Werninghaus C; Brewe F; Wahn U; Niggemann B; Beyer K
Allergy; 2007 Nov; 62(11):1261-9. PubMed ID: 17919140
[TBL] [Abstract][Full Text] [Related]
34. IgE-facilitated antigen presentation: role in allergy and the influence of allergen immunotherapy.
Wilcock LK; Francis JN; Durham SR
Immunol Allergy Clin North Am; 2006 May; 26(2):333-47, viii-ix. PubMed ID: 16701148
[TBL] [Abstract][Full Text] [Related]
35. Allergen immunotherapy.
Frew AJ
J Allergy Clin Immunol; 2010 Feb; 125(2 Suppl 2):S306-13. PubMed ID: 20176266
[TBL] [Abstract][Full Text] [Related]
36. Treatment of respiratory allergy with allergy immunotherapy tablets.
Bachert C
Allergy; 2011 Jul; 66 Suppl 95():57-9. PubMed ID: 21668858
[TBL] [Abstract][Full Text] [Related]
37. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
Panzner P; Petrás M; Sýkora T; Lesná I
Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
[TBL] [Abstract][Full Text] [Related]
38. Mammalian milk allergy: avoidance strategies and oral desensitization.
Skripak JM; Wood RA
Curr Opin Allergy Clin Immunol; 2009 Jun; 9(3):259-64. PubMed ID: 19365261
[TBL] [Abstract][Full Text] [Related]
39. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
[TBL] [Abstract][Full Text] [Related]
40. Allergen-related approaches to immunotherapy.
Rolland JM; Gardner LM; O'Hehir RE
Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
